Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral sclerosis
CV Ly, TM Miller - Current opinion in neurology, 2018 - journals.lww.com
CV Ly, TM Miller
Current opinion in neurology, 2018•journals.lww.comEmerging antisense oligonucleotide and viral therapies for a... : Current Opinion in
Neurology Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral
sclerosis : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle
navigation Subscribe Register Login Articles & Issues Videos For Authors Journal Info
Advanced Search October 2018 - Volume 31 - Issue 5 Previous Article Next Article MOTOR …
Neurology Emerging antisense oligonucleotide and viral therapies for amyotrophic lateral
sclerosis : Current Opinion in Neurology Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle
navigation Subscribe Register Login Articles & Issues Videos For Authors Journal Info
Advanced Search October 2018 - Volume 31 - Issue 5 Previous Article Next Article MOTOR …
Summary
Advances in preclinical and clinical studies of ASO and viral directed approaches to neuromuscular disease, particularly ALS, indicate that these approaches have high specificity and are relatively well tolerated.
Lippincott Williams & Wilkins